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each group developed atrial fibrillation, one had a CABG and seven stopped for compli-
ance reasons. Conclusions: Long term training in stable heart failure is a safe means to
improve functional capacity and autonomic dysfunction. Mean heart rate, norepinephrine
and SDNN were improved significantly,the last even more pronounced in the subgroup
with SDNN<100. The conversion of a positive TWA-test in 6 patients in the training group
could used for therapeutic intervention.
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1164-125 Development of Murine Fibrotic Cardiomyopathy Is 
Dependent on Monocyte Chemoattractant Protein 1
Oliver Dewald, Guofeng Ren, Christina Klemm, Kim Winkelmann, Anna Koerting, George 
Taffet, Lloyd H. Michael, Mark L. Entman, Nikolaos G. Frangogiannis, Baylor College of 
Medicine, Houston, TX
Background: Repetitive brief myocardial ischemia and reperfusion (I/R) is implicated in
the pathogenesis of ventricular dysfunction in ischemic cardiomyopathy and myocardial
hibernation. In a murine model of repetitive brief I/R, we reported a reversible fibrotic car-
diomyopathy in the absence of myocardial infarction, resembling the pathomorphology of
human hibernating myocardium. Much like regional dysfunction in patients, repetitive
brief murine I/R was accompanied by induction of the chemokine Monocyte Chemoat-
tractant Protein (MCP)-1. Accordingly, we examined the role of MCP-1 in the pathogene-
sis of murine cardiomyopathy.
Methods: C57/Bl6 mice undergoing daily 15 min coronary occlusions followed by reper-
fusion, received i.p. MCP-1 neutralizing antibody, or vehicle, after the end of each
ischemia episode. After echocardiographic examination, hearts were processed for histo-
logical and RNA studies.
Results: After 3-5 days of repetitive I/R, chemokine induction in ischemic hearts was
accompanied by interstitial macrophage infiltration. After 7 days of repetitive I/R, marked
interstitial fibrosis was noted in the ischemic area, accompanied by echocardiographic
evidence of global ventricular dysfunction and segmental hypocontractility of the anterior
wall. MCP-1 neutralization did not affect macrophage infiltration in the ischemic myocar-
dium, but significantly inhibited interstitial fibrosis (anterior wall, collagen-stained area,
vehicle 21.5±6.6 % vs. MCP-1 antibody 12.9±2.8 %, P<0.05). Also, MCP-1 inhibition
attenuated left ventricular dysfunction (fractional shortening, 35.1±1.2 % vs. 42.6±1.7 %,
P<0.05) and decreased regional hypocontractility (anterior wall thickening, 35.7±2.4 %
vs. 60.9±3.0 %, P<0.05). MCP-1 antibody-treated mice showed decreased expression of
the matricellular protein Osteopontin 1, a marker of tissue remodeling, after 3 days of I/R.
Conclusion: MCP-1 plays a crucial role in the pathogenesis of murine ischemic cardi-
omyopathy through effects, which appear to be independent of its leukotactic properties.
Endogenous expression of MCP-1 may be important in regulating fibrosis in patients with
ischemic cardiomyopathy.
1164-126 Characteristics of Duchenne and Becker Muscular 
Dystrophy Patients in the Pediatric Cardiomyopathy 
Registry
David Connuck, Lynn Sleeper, Jeffrey Towbin, Steven Colan, Gerald Cox, Leigha 
Cuniberti, John Orav, Bonnie Anne Salbert, Steven Lipshultz, University of Rochester, 
Rochester, NY, New England Research Institutes, Watertown, MA
Background: The NHLBI-sponsored PCMR is a multicenter study of pediatric cardiomy-
opathy (CM) in North America. Data have been collected on patients with Duchenne
(DMD) and Becker (BMD) muscular dystrophy.
Methods: As of May 2003, the Registry is comprised of 2,602 children and adolescents
who presented to a pediatric cardiologist with CM from 1990 to present. Inclusion criteria
include 1) <18.0 years at time of CM diagnosis; 2) echocardiographic evidence of CM,
defined as >2 left ventricular measurements (ejection fraction, posterior wall thickness,
septal thickness, end diastolic dimension or volume) exceeding 2 SD or an echocardio-
graphic pattern of CM; or 3) a pathologic diagnosis of CM on autopsy or endomyocardial
biopsy; or 4) other clinical evidence provided by the cardiologist.
Results: The PCMR includes 134 patients with DMD or BMD. 99% are male, 27% are
non-white. We observed 39 DMD and 1 BMD deaths; 0 DMD transplants and 6 BMD
transplants, for a total of 39 DMD and 7 BMD death/transplant events. 25% of all DMD
patients die within 2.2 years following CM diagnosis (defined as meeting PCMR entry cri-
teria) and 50% die within 5.3 years (p=.219 vs. BMD). 25% of all BMD pts die or are
transplanted within 0.4 years following CM diagnosis and 50% die or are transplanted
within 1.3 years (p=.063 vs. DMD). At diagnosis patients with BMD are somewhat more
likely (p=.143) to have mitral regurgitation (60% vs. 24%), particularly those with conges-
tive heart failure (100% vs. 40%), and a higher LV end diastolic dimension(3.0 vs. 1.3
BSA-adjusted Z-score, p=.002) than patients with DMD. Similarities between the two
groups include a mean age of CM diagnosis of 14 years, with 1/3 having congestive
heart failure at enrollment. Non-muscular dystrophy patients in the PCMR have a lower
mortality rate than the BMD/DMD group (p<0.0001).
Conclusions: Current observations suggest that the DMD/BMD groups have different
clinical characteristics at the time of CM diagnosis, with mitral regurgitation, LV dilation
and heart failure being more common in the BMD patients. Following diagnosis for CM,
DMD patients have a higher mortality rate and BMD patients may have a higher trans-
plant rate than pediatric patients with other types of CM.
1164-127 Whole Body, Myocardial, and Coronary Vascular Insulin 
Resistance in Conscious Dogs With Pacing Induced 
Dilated Cardiomyopathy
Amy Schuett, Lazaros A. Nikolaidis, Teresa Hentosz, Carol Stolarski, Aaron Doverspike, 
Rhonda Huerbin, Lee Zourelias, Richard P. Shannon, Dariush Elahi, Allegheny General 
Hospital, Pittsburgh, PA
Background: Previous work from our laboratory has demonstrated reduced basal myo-
cardial glucose uptake in conscious dogs with advanced DCM as they transition to a dec-
ompensated state. The cellular basis of the impaired glucose uptake involves impaired
GLUT-4 translocation. Our goal was to determine whether the development of insulin
resistance in DCM was limited to the myocardium or involved whole body insulin resis-
tance and whether the impaired action of insulin extended beyond its metabolic effects.
Methods: We studied 8 conscious, chronically instrumented dogs under normal fasting
circumstances before (Con) and after the development of advanced DCM induced by 4-5
weeks of rapid pacing using the hyperinsulinemic-euglycemic clamp technique (480
pmol•m-2•min-1). We measured whole body and myocardial glucose uptake and vascu-
lar and hemodynamic responses to hyperinsulinemia.
Results: The development of DCM was associated with significant (*p<0.05) increases in
plasma norepinephrine levels (Con: 125±26; DCM: 378±42 pg/ml*), plasma insulin (Con:
27±4; DCM: 72±6 pmol/L*) and NEFA (Con: 236±43; DCM: 612±59 µmol/ l*). Plasma
insulin levels were raised acutely to 1100 pmol/L and plasma glucose clamped at 5 mM
for 120 minutes. Within 30 min., NEFA fell to < 50 µmol/L in both groups. Whole body glu-
cose disposition was less in DCM (52±3 µmol•kg-1•min-1*) compared to Con (66±3
µmol•kg-1•min-1). Myocardial glucose uptake increased in both groups during hyperin-
sulinemia, but to a lesser extent in DCM (1.6 ±0.4 to 4.2±1.1 µmol/min*) than Con (2.3
±0.6 to 13.1±3.1 µmol/min). Hyperinsulinemia was associated with significant increases
in coronary blood flow in Con (20±3 to 31±5 ml*), but had no effect in DCM (20±2 to 22
±2 ml).
Conclusions: With DCM, myocardial and total peripheral glucose uptake is reduced due
to overall insulin resistance. Insulin mediated suppression of NEFA remains intact. Insulin
resistance is also evident in the impaired vascular response to hyperinsulinemia in DCM.
1164-128 Endothelial Function of the Coronary Microcirculation Is 
Impaired in Patients With Myocardial Virus Persistence
Katja B. Vallbracht, Peter L. Schwimmbeck, Uwe Kuehl, Bettina Seeberg, Heinz-Peter 
Schultheiss, Charité Medical University, Benjamin Franklin Hospital, Berlin, Germany
Background
Myocardial virus persistence can be associated with myocardial inflammation and endot-
helial activation. The aim of this study is to investigate the impact of myocardial virus per-
sistence on endothelial function (ENF) of the coronary microcirculation.
Methods
In 71 patients with suspected cardiomyopathy, myocardial biopsies were examined for
virus persistence (PCR) and inflammation (immunohistology). Endothelial function of the
coronary microcirculation was examined during heart catheterization, measuring diame-
ter (QCA) and velocity changes (intracoronary doppler) of the mid LAD in response to
locally administered acetylcholine. Coronary blood flow was calculated (CBF). Endothe-
lium independent vasoreactivity to adenosine was assessed.
Results
Mean age of the 37 male and 34 female patients was 43+-13 years, ejection fraction was
64+-11%. In 42 patients, adeno-, entero-, parvo- or HHV6-virus was detected via PCR,
29 patients had no virus. ENF of the coronary microcirculation was significantly impaired
in patients with myocardial virus persistence, as compared to controls: dCBF-V 25+-85%,
dCBF-Co 103+-118% (p=0.004). In 51 patients, myocardial inflammation was detected
by immunohistology (InfCM), of those, 31 had virus persistence, 20 had no virus. dCBF
was significantly impaired in patients with myocardial virus persistence, as compared to
controls: dCBF-InfCM-V 16+-88%, dCBF-InfCM-Co 72+-114% (p=0.101). In 20 patients,
immunohistology of the myocardial biopsies were normal (Co), of those, 11 had virus per-
sistence and 9 had no virus. dCBF was impaired in patients with myocardial virus persis-
tence, as compared to controls: dCBF-Co-V 51+-72%, dCBF-Co-Co 175+-97 (p=0.006).
Endothelium independent vasodilation was not influenced significantly.
Conclusions
Exercise group Control group
pre post pre post
VO2AT
ml/min/kg
11,5+-1,9 14,0+-2,5** 12,3+-2,7 11,9+-2,5
VO2peak
ml/min/kg
18,4+-4,5 21,7+-4,5** 18,7+-4,6 17,7+-4,3
mean HR
beats
78,6+-12,2 71,8+-11,4* 72,4+-10,3 76,5+-10,2
norepinehrine
ng/l
592,3+-336,1 431,4+-215,0* 487,1+-381,6 713,4+-487,9**
SDNN 102,4+-50,6 117,3+-37,9* 105,2+-37,0 108,2+-41,3
RMSSD 25,7+-23,4 32,3+-26,1 31,2+-29,7 27,9+-24,4
SDANN 90,2+-43,5 101,9+-35,4 90,5+-29,0 96,5+-38,2
SDNN<100 70,1+-20,0 101,0+-27,4** 75,4+-20,4 85,0+-35,1
TWA positive 15 8 / 1 id * 18 17 / 1 id
